← Back to Search

Tyrosine Kinase Inhibitor

Fostamatinib (150 mg twice daily for 14 days) + Standard of Care for Coronavirus

Phase 3
Waitlist Available
Research Sponsored by Rigel Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights
Pivotal Trial

Summary

This trial is testing a new drug to see if it can help treat people with COVID-19. The study is well-designed and will help researchers understand if the drug is safe and effective.

Eligible Conditions
  • Coronavirus
  • SARS
  • Severe Acute Respiratory Syndrome
  • Pneumonia
  • Viral Pneumonia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of days on oxygen from randomization on Day 1 to Day 29
Secondary study objectives
All-cause mortality by Day 29.
All-cause mortality by Day 60
Mean change from baseline over time in clinical status score using the 8-point ordinal scale, to the average from Day 5 through Day 15.
+4 more

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Fostamatinib (150 mg twice daily for 14 days) + Standard of CareActive Control1 Intervention
Fostamatinib (150 mg twice daily for 14 days) + Standard of Care
Group II: Placebo (twice daily for 14 days) + Standard of CarePlacebo Group1 Intervention
Placebo (twice daily for 14 days) + Standard of Care

Find a Location

Who is running the clinical trial?

Rigel PharmaceuticalsLead Sponsor
35 Previous Clinical Trials
3,712 Total Patients Enrolled
~62 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top